SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-20-009706
Filing Date
2020-04-24
Accepted
2020-04-24 16:33:39
Documents
5
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEFA14A nc10007781x2_defa14a.htm DEFA14A 41278
2 nc10007781x2_img1.jpg GRAPHIC 205167
3 nc10007781x2_img2.jpg GRAPHIC 399125
4 nc10007781x2_img3.jpg GRAPHIC 81373
5 nc10007781x2_img4.jpg GRAPHIC 34360
  Complete submission text file 0001140361-20-009706.txt   1034259
Mailing Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005
Business Address 3280 BAYSHORE BOULEVARD BRISBANE CA 94005 (415) 328-5504
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38470 | Film No.: 20815521
SIC: 2834 Pharmaceutical Preparations